Literature DB >> 33447560

Sentinel lymph node mapping in high-risk endometrial cancer: a systematic review and meta-analysis.

Qiang Ji1, Xiuying Wang1, Jiyong Jiang1, Liyan Chen1.   

Abstract

BACKGROUND: In the staging of endometrial cancer (EC), the role of sentinel lymph node (SLN) mapping for high-risk EC is still unclear.
METHODS: Two authors independently reviewed abstracts and full-text articles for inclusion and assessed study quality. English studies published in PubMed, Embase, and Cochrane Library before 20th SEP, 2019 were retrieved to perform a systematic evaluation and meta-analysis which evaluate the detection rate and diagnostic accuracy of SLN mapping in high-risk EC. Statistical analysis was conducted using stata14.0 software.
RESULTS: A total of 12 studies were included, including 758 high-risk EC patients. The detection rate of SLN mapping was 84.8% (95% CI, 79.9-89.6%). The pooled bilateral detection rate was 67.0% (95% CI, 56.8-77.3%). The pooled para-aortic detection rate was 8.4% (95% CI, 1.8-14.9%). The pooled sensitivity was 87% (95% CI, 79-92%), and the pooled specificity was 98% (95% CI, 96-99%). Pooled negative predictive value (NPV) was 97.7% (95% CI, 96.4-99.1%), AUC =0.99 (95% CI, 0.97-0.099).
CONCLUSIONS: SLN mapping still has a high detection rate and diagnostic accuracy in high-risk EC. SLN mapping is a reliable alternative to systematic lymph node dissection, but its prognostic effect on high-risk EC is yet to be further studied and verified by large sample studies. 2020 Gland Surgery. All rights reserved.

Entities:  

Keywords:  Endometrial cancer (EC); high-risk; sentinel lymph node (SLN)

Year:  2020        PMID: 33447560      PMCID: PMC7804562          DOI: 10.21037/gs-20-807

Source DB:  PubMed          Journal:  Gland Surg        ISSN: 2227-684X


  26 in total

1.  Prospective assessment of the prevalence of pelvic, paraaortic and high paraaortic lymph node metastasis in endometrial cancer.

Authors:  Sanjeev Kumar; Karl C Podratz; Jamie N Bakkum-Gamez; Sean C Dowdy; Amy L Weaver; Michaela E McGree; William A Cliby; Gary L Keeney; Gillian Thomas; Andrea Mariani
Journal:  Gynecol Oncol       Date:  2013-10-09       Impact factor: 5.482

2.  The importance of applying a sentinel lymph node mapping algorithm in endometrial cancer staging: beyond removal of blue nodes.

Authors:  Joyce N Barlin; Fady Khoury-Collado; Christine H Kim; Mario M Leitao; Dennis S Chi; Yukio Sonoda; Kaled Alektiar; Deborah F DeLair; Richard R Barakat; Nadeem R Abu-Rustum
Journal:  Gynecol Oncol       Date:  2012-02-22       Impact factor: 5.482

3.  Sentinel node biopsy for the management of early stage endometrial cancer: long-term results of the SENTI-ENDO study.

Authors:  Emile Daraï; Gil Dubernard; Anne-Sophie Bats; Denis Heitz; Patrice Mathevet; Henri Marret; Denis Querleu; François Golfier; Eric Leblanc; Roman Rouzier; Marcos Ballester
Journal:  Gynecol Oncol       Date:  2014-10-22       Impact factor: 5.482

4.  Prospective study of sentinel lymph node mapping for endometrial cancer.

Authors:  Shinichi Togami; Toshihiko Kawamura; Mika Fukuda; Shintaro Yanazume; Masaki Kamio; Hiroaki Kobayashi
Journal:  Int J Gynaecol Obstet       Date:  2018-09-19       Impact factor: 3.561

5.  A Prospective Study of Sentinel Lymph Node Mapping for Endometrial Cancer: Is It Effective in High-Risk Subtypes?

Authors:  Lei Ye; ShuangDi Li; Wen Lu; QiZhi He; YiRan Li; BiLan Li; XiaoJun Wang; Qin Yan; XiaoPing Wan
Journal:  Oncologist       Date:  2019-07-03

6.  A prospective evaluation of the sentinel node mapping algorithm in endometrial cancer and correlation of its performance against endometrial cancer risk subtypes.

Authors:  Anupama Rajanbabu; Reshu Agarwal
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2018-03-13       Impact factor: 2.435

7.  Comparison of a sentinel lymph node and a selective lymphadenectomy algorithm in patients with endometrioid endometrial carcinoma and limited myometrial invasion.

Authors:  Ane Gerda Zahl Eriksson; Jen Ducie; Narisha Ali; Michaela E McGree; Amy L Weaver; Giorgio Bogani; William A Cliby; Sean C Dowdy; Jamie N Bakkum-Gamez; Nadeem R Abu-Rustum; Andrea Mariani; Mario M Leitao
Journal:  Gynecol Oncol       Date:  2015-12-31       Impact factor: 5.482

8.  International Federation of Gynecology and Obstetrics staging of endometrial cancer 1988.

Authors:  J J Mikuta
Journal:  Cancer       Date:  1993-02-15       Impact factor: 6.860

9.  Sentinel Lymph Node Biopsy in the Treatment of Endometrial Cancer: Why We Fail? Results of a Prospective Multicenter Study on the Factors Associated with Failure of Node Mapping with Indocyanine Green.

Authors:  Manuel Maria Ianieri; Andrea Puppo; Antonia Novelli; Federica Campolo; Tommaso Staniscia; Giuseppe Di Martino; Elisa Piovano; Francesco Bruni; Giovanni Roviglione; Daniele Mautone; Marcello Ceccaroni
Journal:  Gynecol Obstet Invest       Date:  2019-01-18       Impact factor: 2.031

10.  A retrospective validation study of sentinel lymph node mapping for high-risk endometrial cancer.

Authors:  Tian Wang; Yuanjing Hu; Ya He; Peisong Sun; Zhengchen Guo
Journal:  Arch Gynecol Obstet       Date:  2019-02-12       Impact factor: 2.344

View more
  2 in total

1.  The effect of surgical approach on the outcomes and prognosis of high-risk histologic endometrioid carcinomas.

Authors:  Zhihong Han; Zhong Zheng; Kai Tao; Yanping Yu; Jinping Wu; Xiaofei Tian
Journal:  Gland Surg       Date:  2021-01

Review 2.  Sentinel Lymph Node Mapping in High-Grade Endometrial Cancer.

Authors:  Lina Salman; Maria C Cusimano; Zibi Marchocki; Sarah E Ferguson
Journal:  Curr Oncol       Date:  2022-02-14       Impact factor: 3.677

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.